Janux Therapeutics, Inc. Files 8-K Report with SEC: Company Information and Key Disclosures (April 28, 2026)
Janux Therapeutics, Inc. 8-K Filing – Board of Directors Rec...
Sign in to continue:
Janux Therapeutics, Inc. 8-K Filing – Board of Directors Rec...
Orange County Bancorp, Inc. Reports Record First Quarter 202...
Corvex, Inc. (NASDAQ: MOVE) Files 8-K: Change in Independent...
Vista Gold Corp Announces AGM Results and Mt Todd Project Up...
Roman DBDR Acquisition Corp. II Appoints New Director and Ad...
Ashland Inc. Q2 2026 Earnings: Cash Flow Strength, Guidance ...
RENN Fund, Inc. - Detailed Investor Update (8-K Filing April...
Broker: CGS International Date of Report: April 28, 2026 Exc...
Medallion Financial Corp. Completes \$75 Million Private Pla...
Broker: CGS International Date of Report: April 29, 2026 Ex...